Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Understanding the factors affecting credit card rewards accumulation can help you boost your earnings. Discover what influences your rewards strategy.
5,496 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A clear, reader-friendly breakdown of Acadia’s Q4 2025 earnings. We unpack revenue trends, pipeline progress, and key...
Walmart is redefining retail competition with a bold mix of groceries, everyday low prices, and omnichannel strength....
Two bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
An institutional investor disclosed a new $6.5 million stake in Middleby. This article uncovers what’s behind that be...
Institutional moves can hint at mood, but they don’t guarantee gains. A large stake in Capri Holdings by DME Capital ...
As Agilent prepares to reveal its Q1 2026 results, investors want clarity on growth signals and margins. This guide b...
Mullen’s share path remains highly uncertain as the EV market shifts and capital needs loom. This report maps potenti...
The latest Shake Shack earnings sparked a notable stock rally. This article breaks down the factors driving the move,...
Novocure faces a pivotal year as TTFields therapy expands and reimbursement pathways evolve. This guide breaks down w...
As Veracyte approaches its Q4 2025 earnings, investors want a clear view of revenue momentum, margins, and reimbursem...
Institutional activity in Bitcoin ETFs is more nuanced than daily inflows suggest. This piece examines how market mak...